Industry News (Clinical Trials)

510k Submission Pre-Clinical Cancer Trial Announced

Published in AIDS Weekly, August 18th, 1997

HemoCleanse Inc., West Lafayette, Indiana, in conjunction with IDT Inc. announced that it has submitted a 510(k) Notification with the U.S. Food and Drug Administration (FDA) to request market clearance for the ThermoChem-HT System for use in Intraperitoneal Hyperthermic Chemotherapy (IPHC).

The ThermoChem-HT System was formerly known as the BioLogic-HTA, a part of the BioLogic-HT System which is now called the ThermoChem System. The ThermoChem System currently is being studied in whole body hyperthermia treatment of cancer and HIV/AIDS. The system name was changed to better identify the products and their intended markets.

The ThermoChem-HT System...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-08-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry